Market Overview

Morning Market Movers

Share:
Related ALNY
Benzinga's Top Upgrades, Downgrades For July 27, 2017
Analyst: Shire Shares Should Rebound, But Sustained Rally Unlikely
Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells Centene ... (GuruFocus)
Related MRK
You Can't Quit, Because You're Fired! Trump Disbands Manufacturing Council, Policy Forum
Market Reaction To Bristol-Myers' Mixed Clinical Results: 'A Little Excessive'

Alnylam Pharmaceuticals (NASDAQ: ALNY) rose 34.16% to $88.83 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Rexahn Pharmaceuticals (NYSE: RNN) jumped 33.77% to $1.53. Rexahn Pharmaceuticals shares have jumped 235.29% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period.

Rosetta Genomics (NASDAQ: ROSG) moved up 33.23% to $4.25 after the company reported that it has signed a master service provider agreement with a major global biopharmaceutical company.

Teche Holding Company (NYSE: TSH) shares jumped 28.44% to $70.00 after IBERIABANK (NASDAQ: IBKC) announced an agreement to acquire Teche Holding.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (ALNY + IBKC)

View Comments and Join the Discussion!